Blinatumomab addition to chemotherapy significantly improves survival and reduces relapse in pediatric B-cell acute ...

Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL)—the most common ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

Journalist and author Tatiana Schlossberg, President John F. Kennedy's granddaughter, Caroline Kennedy's daughter and Jack Sch l ossberg's sister, revealed earlier this month she has been diagnosed ...

Schlossberg says she was diagnosed shortly after welcoming her second child. Tatiana Schlossberg's surprising revelation that she is battling terminal cancer has put a spotlight on the type of cancer ...

Komzifti, a menin inhibitor, is FDA-approved for relapsed/refractory AML with NPM1 mutation, showing efficacy in the KO-MEN-001 trial. The trial reported a 21.4% CR plus CRh rate and a five-month ...

MIAMI, FLORIDA (Nov. 13, 2025) – Below are titles – linked to more than 100 poster abstracts – that will be presented at ASH 2025 involving researchers from Sylvester Comprehensive Cancer Center and ...

Dear Dr. Roach: My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial ...

Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers. This is the main finding of the latest research by Dr. Marcus Buschbeck and Dr.

For Sinisa Dovat, PhD, the best place to make a difference in the lives of those in medical need is also the best place to set the foundations for future medical advancements. A physician-scientist ...

The National Comprehensive Cancer Network guidelines for pediatric and adult acute lymphoblastic leukemia (ALL) provide recommendations on standard treatment approaches based on the current evidence.